Global Human Coagulation Factor VIII Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
The global Medical Vacuum Regulator market size is predicted to grow from US$ 166 million in 2025 to US$ 235 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
Medical Vacuum Regulator is a medical device that converts the high-pressure vacuum that is supplied by the hospitals central vacuum system to a safe level for use on a patient.
The vacuum regulator is used to measure and adjust the vacuum level within the context of medical suction. It enables to drain substances out of the patient’s body during surgical procedures. The vacuum regulator should be connected to a vacuum source on the wall either using a direct probe or a rail mounting system. It should be associated with a collection jar and a suction hose.
Global Medical Vacuum Regulator key players include Ohio Medical, Amico, Precision Medical, Air Liquid Healthcare, Integral, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, having a total share about 55 percent.
In terms of product, Analog Vacuum Regulator is the largest segment, with a share about 70%. And in terms of application, the largest application is in Clinical, followed by Surgical.
LP Information, Inc. (LPI) ' newest research report, the “Medical Vacuum Regulator Industry Forecast” looks at past sales and reviews total world Medical Vacuum Regulator sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Vacuum Regulator sales for 2025 through 2031. With Medical Vacuum Regulator sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Vacuum Regulator industry.
This Insight Report provides a comprehensive analysis of the global Medical Vacuum Regulator landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Vacuum Regulator portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Vacuum Regulator market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Vacuum Regulator and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Vacuum Regulator.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Vacuum Regulator market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Analog Vacuum Regulator
- Digital Vacuum Regulator
- Clinically
- Surgical
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ohio Medical
- Amico
- Precision Medical
- Air Liquid Healthcare
- Integral
- Allied Healthcare Products
- Shanghai Amcaremed Technology
- Acare
- Hersill
What is the 10-year outlook for the global Medical Vacuum Regulator market?
What factors are driving Medical Vacuum Regulator market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Vacuum Regulator market opportunities vary by end market size?
How does Medical Vacuum Regulator break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor VIII Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Coagulation Factor VIII by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Coagulation Factor VIII by Country/Region, 2020, 2024 & 2031
2.2 Human Coagulation Factor VIII Segment by Type
2.2.1 Recombinant Factor VIII
2.2.2 Plasma-derived Factor VIII
2.3 Human Coagulation Factor VIII Sales by Type
2.3.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
2.3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Coagulation Factor VIII Sale Price by Type (2020-2025)
2.4 Human Coagulation Factor VIII Segment by Application
2.4.1 Hemophilia A
2.4.2 Spontanous / Trauma
2.4.3 Surgical
2.4.4 Other
2.5 Human Coagulation Factor VIII Sales by Application
2.5.1 Global Human Coagulation Factor VIII Sale Market Share by Application (2020-2025)
2.5.2 Global Human Coagulation Factor VIII Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Coagulation Factor VIII Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Coagulation Factor VIII Breakdown Data by Company
3.1.1 Global Human Coagulation Factor VIII Annual Sales by Company (2020-2025)
3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
3.2 Global Human Coagulation Factor VIII Annual Revenue by Company (2020-2025)
3.2.1 Global Human Coagulation Factor VIII Revenue by Company (2020-2025)
3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
3.3 Global Human Coagulation Factor VIII Sale Price by Company
3.4 Key Manufacturers Human Coagulation Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Coagulation Factor VIII Product Location Distribution
3.4.2 Players Human Coagulation Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN COAGULATION FACTOR VIII BY GEOGRAPHIC REGION
4.1 World Historic Human Coagulation Factor VIII Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Coagulation Factor VIII Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Coagulation Factor VIII Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Coagulation Factor VIII Market Size by Country/Region (2020-2025)
4.2.1 Global Human Coagulation Factor VIII Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Coagulation Factor VIII Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Coagulation Factor VIII Sales Growth
4.4 APAC Human Coagulation Factor VIII Sales Growth
4.5 Europe Human Coagulation Factor VIII Sales Growth
4.6 Middle East & Africa Human Coagulation Factor VIII Sales Growth
5 AMERICAS
5.1 Americas Human Coagulation Factor VIII Sales by Country
5.1.1 Americas Human Coagulation Factor VIII Sales by Country (2020-2025)
5.1.2 Americas Human Coagulation Factor VIII Revenue by Country (2020-2025)
5.2 Americas Human Coagulation Factor VIII Sales by Type (2020-2025)
5.3 Americas Human Coagulation Factor VIII Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Coagulation Factor VIII Sales by Region
6.1.1 APAC Human Coagulation Factor VIII Sales by Region (2020-2025)
6.1.2 APAC Human Coagulation Factor VIII Revenue by Region (2020-2025)
6.2 APAC Human Coagulation Factor VIII Sales by Type (2020-2025)
6.3 APAC Human Coagulation Factor VIII Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Coagulation Factor VIII by Country
7.1.1 Europe Human Coagulation Factor VIII Sales by Country (2020-2025)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Country (2020-2025)
7.2 Europe Human Coagulation Factor VIII Sales by Type (2020-2025)
7.3 Europe Human Coagulation Factor VIII Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Coagulation Factor VIII by Country
8.1.1 Middle East & Africa Human Coagulation Factor VIII Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Coagulation Factor VIII Sales by Type (2020-2025)
8.3 Middle East & Africa Human Coagulation Factor VIII Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII
10.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
10.4 Industry Chain Structure of Human Coagulation Factor VIII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Coagulation Factor VIII Distributors
11.3 Human Coagulation Factor VIII Customer
12 WORLD FORECAST REVIEW FOR HUMAN COAGULATION FACTOR VIII BY GEOGRAPHIC REGION
12.1 Global Human Coagulation Factor VIII Market Size Forecast by Region
12.1.1 Global Human Coagulation Factor VIII Forecast by Region (2026-2031)
12.1.2 Global Human Coagulation Factor VIII Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Coagulation Factor VIII Forecast by Type (2026-2031)
12.7 Global Human Coagulation Factor VIII Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Human Coagulation Factor VIII Product Portfolios and Specifications
13.1.3 Takeda Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Human Coagulation Factor VIII Product Portfolios and Specifications
13.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Human Coagulation Factor VIII Product Portfolios and Specifications
13.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Human Coagulation Factor VIII Product Portfolios and Specifications
13.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Grifols
13.5.1 Grifols Company Information
13.5.2 Grifols Human Coagulation Factor VIII Product Portfolios and Specifications
13.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Grifols Main Business Overview
13.5.5 Grifols Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Human Coagulation Factor VIII Product Portfolios and Specifications
13.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
13.7 Octapharma
13.7.1 Octapharma Company Information
13.7.2 Octapharma Human Coagulation Factor VIII Product Portfolios and Specifications
13.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Octapharma Main Business Overview
13.7.5 Octapharma Latest Developments
13.8 NovoNordisk
13.8.1 NovoNordisk Company Information
13.8.2 NovoNordisk Human Coagulation Factor VIII Product Portfolios and Specifications
13.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 NovoNordisk Main Business Overview
13.8.5 NovoNordisk Latest Developments
13.9 Greencross
13.9.1 Greencross Company Information
13.9.2 Greencross Human Coagulation Factor VIII Product Portfolios and Specifications
13.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Greencross Main Business Overview
13.9.5 Greencross Latest Developments
13.10 Kedrion
13.10.1 Kedrion Company Information
13.10.2 Kedrion Human Coagulation Factor VIII Product Portfolios and Specifications
13.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kedrion Main Business Overview
13.10.5 Kedrion Latest Developments
13.11 BPL
13.11.1 BPL Company Information
13.11.2 BPL Human Coagulation Factor VIII Product Portfolios and Specifications
13.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 BPL Main Business Overview
13.11.5 BPL Latest Developments
13.12 Hualan Bio
13.12.1 Hualan Bio Company Information
13.12.2 Hualan Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hualan Bio Main Business Overview
13.12.5 Hualan Bio Latest Developments
13.13 RAAS
13.13.1 RAAS Company Information
13.13.2 RAAS Human Coagulation Factor VIII Product Portfolios and Specifications
13.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 RAAS Main Business Overview
13.13.5 RAAS Latest Developments
13.14 SinoCellTech
13.14.1 SinoCellTech Company Information
13.14.2 SinoCellTech Human Coagulation Factor VIII Product Portfolios and Specifications
13.14.3 SinoCellTech Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SinoCellTech Main Business Overview
13.14.5 SinoCellTech Latest Developments
13.15 Taibang Bio
13.15.1 Taibang Bio Company Information
13.15.2 Taibang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.15.3 Taibang Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Taibang Bio Main Business Overview
13.15.5 Taibang Bio Latest Developments
13.16 Huarun Boya
13.16.1 Huarun Boya Company Information
13.16.2 Huarun Boya Human Coagulation Factor VIII Product Portfolios and Specifications
13.16.3 Huarun Boya Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Huarun Boya Main Business Overview
13.16.5 Huarun Boya Latest Developments
13.17 Shuanglin Bio
13.17.1 Shuanglin Bio Company Information
13.17.2 Shuanglin Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.17.3 Shuanglin Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Shuanglin Bio Main Business Overview
13.17.5 Shuanglin Bio Latest Developments
13.18 Yuandashuyang
13.18.1 Yuandashuyang Company Information
13.18.2 Yuandashuyang Human Coagulation Factor VIII Product Portfolios and Specifications
13.18.3 Yuandashuyang Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Yuandashuyang Main Business Overview
13.18.5 Yuandashuyang Latest Developments
13.19 Weiguang Bio
13.19.1 Weiguang Bio Company Information
13.19.2 Weiguang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.19.3 Weiguang Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Weiguang Bio Main Business Overview
13.19.5 Weiguang Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Coagulation Factor VIII Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Human Coagulation Factor VIII by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Human Coagulation Factor VIII by Country/Region, 2020, 2024 & 2031
2.2 Human Coagulation Factor VIII Segment by Type
2.2.1 Recombinant Factor VIII
2.2.2 Plasma-derived Factor VIII
2.3 Human Coagulation Factor VIII Sales by Type
2.3.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
2.3.2 Global Human Coagulation Factor VIII Revenue and Market Share by Type (2020-2025)
2.3.3 Global Human Coagulation Factor VIII Sale Price by Type (2020-2025)
2.4 Human Coagulation Factor VIII Segment by Application
2.4.1 Hemophilia A
2.4.2 Spontanous / Trauma
2.4.3 Surgical
2.4.4 Other
2.5 Human Coagulation Factor VIII Sales by Application
2.5.1 Global Human Coagulation Factor VIII Sale Market Share by Application (2020-2025)
2.5.2 Global Human Coagulation Factor VIII Revenue and Market Share by Application (2020-2025)
2.5.3 Global Human Coagulation Factor VIII Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Human Coagulation Factor VIII Breakdown Data by Company
3.1.1 Global Human Coagulation Factor VIII Annual Sales by Company (2020-2025)
3.1.2 Global Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
3.2 Global Human Coagulation Factor VIII Annual Revenue by Company (2020-2025)
3.2.1 Global Human Coagulation Factor VIII Revenue by Company (2020-2025)
3.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
3.3 Global Human Coagulation Factor VIII Sale Price by Company
3.4 Key Manufacturers Human Coagulation Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Coagulation Factor VIII Product Location Distribution
3.4.2 Players Human Coagulation Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMAN COAGULATION FACTOR VIII BY GEOGRAPHIC REGION
4.1 World Historic Human Coagulation Factor VIII Market Size by Geographic Region (2020-2025)
4.1.1 Global Human Coagulation Factor VIII Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Human Coagulation Factor VIII Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Human Coagulation Factor VIII Market Size by Country/Region (2020-2025)
4.2.1 Global Human Coagulation Factor VIII Annual Sales by Country/Region (2020-2025)
4.2.2 Global Human Coagulation Factor VIII Annual Revenue by Country/Region (2020-2025)
4.3 Americas Human Coagulation Factor VIII Sales Growth
4.4 APAC Human Coagulation Factor VIII Sales Growth
4.5 Europe Human Coagulation Factor VIII Sales Growth
4.6 Middle East & Africa Human Coagulation Factor VIII Sales Growth
5 AMERICAS
5.1 Americas Human Coagulation Factor VIII Sales by Country
5.1.1 Americas Human Coagulation Factor VIII Sales by Country (2020-2025)
5.1.2 Americas Human Coagulation Factor VIII Revenue by Country (2020-2025)
5.2 Americas Human Coagulation Factor VIII Sales by Type (2020-2025)
5.3 Americas Human Coagulation Factor VIII Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Coagulation Factor VIII Sales by Region
6.1.1 APAC Human Coagulation Factor VIII Sales by Region (2020-2025)
6.1.2 APAC Human Coagulation Factor VIII Revenue by Region (2020-2025)
6.2 APAC Human Coagulation Factor VIII Sales by Type (2020-2025)
6.3 APAC Human Coagulation Factor VIII Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Coagulation Factor VIII by Country
7.1.1 Europe Human Coagulation Factor VIII Sales by Country (2020-2025)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Country (2020-2025)
7.2 Europe Human Coagulation Factor VIII Sales by Type (2020-2025)
7.3 Europe Human Coagulation Factor VIII Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Coagulation Factor VIII by Country
8.1.1 Middle East & Africa Human Coagulation Factor VIII Sales by Country (2020-2025)
8.1.2 Middle East & Africa Human Coagulation Factor VIII Revenue by Country (2020-2025)
8.2 Middle East & Africa Human Coagulation Factor VIII Sales by Type (2020-2025)
8.3 Middle East & Africa Human Coagulation Factor VIII Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII
10.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
10.4 Industry Chain Structure of Human Coagulation Factor VIII
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Coagulation Factor VIII Distributors
11.3 Human Coagulation Factor VIII Customer
12 WORLD FORECAST REVIEW FOR HUMAN COAGULATION FACTOR VIII BY GEOGRAPHIC REGION
12.1 Global Human Coagulation Factor VIII Market Size Forecast by Region
12.1.1 Global Human Coagulation Factor VIII Forecast by Region (2026-2031)
12.1.2 Global Human Coagulation Factor VIII Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Human Coagulation Factor VIII Forecast by Type (2026-2031)
12.7 Global Human Coagulation Factor VIII Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Human Coagulation Factor VIII Product Portfolios and Specifications
13.1.3 Takeda Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Human Coagulation Factor VIII Product Portfolios and Specifications
13.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Human Coagulation Factor VIII Product Portfolios and Specifications
13.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Human Coagulation Factor VIII Product Portfolios and Specifications
13.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Grifols
13.5.1 Grifols Company Information
13.5.2 Grifols Human Coagulation Factor VIII Product Portfolios and Specifications
13.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Grifols Main Business Overview
13.5.5 Grifols Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Human Coagulation Factor VIII Product Portfolios and Specifications
13.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
13.7 Octapharma
13.7.1 Octapharma Company Information
13.7.2 Octapharma Human Coagulation Factor VIII Product Portfolios and Specifications
13.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Octapharma Main Business Overview
13.7.5 Octapharma Latest Developments
13.8 NovoNordisk
13.8.1 NovoNordisk Company Information
13.8.2 NovoNordisk Human Coagulation Factor VIII Product Portfolios and Specifications
13.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 NovoNordisk Main Business Overview
13.8.5 NovoNordisk Latest Developments
13.9 Greencross
13.9.1 Greencross Company Information
13.9.2 Greencross Human Coagulation Factor VIII Product Portfolios and Specifications
13.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Greencross Main Business Overview
13.9.5 Greencross Latest Developments
13.10 Kedrion
13.10.1 Kedrion Company Information
13.10.2 Kedrion Human Coagulation Factor VIII Product Portfolios and Specifications
13.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kedrion Main Business Overview
13.10.5 Kedrion Latest Developments
13.11 BPL
13.11.1 BPL Company Information
13.11.2 BPL Human Coagulation Factor VIII Product Portfolios and Specifications
13.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 BPL Main Business Overview
13.11.5 BPL Latest Developments
13.12 Hualan Bio
13.12.1 Hualan Bio Company Information
13.12.2 Hualan Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Hualan Bio Main Business Overview
13.12.5 Hualan Bio Latest Developments
13.13 RAAS
13.13.1 RAAS Company Information
13.13.2 RAAS Human Coagulation Factor VIII Product Portfolios and Specifications
13.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 RAAS Main Business Overview
13.13.5 RAAS Latest Developments
13.14 SinoCellTech
13.14.1 SinoCellTech Company Information
13.14.2 SinoCellTech Human Coagulation Factor VIII Product Portfolios and Specifications
13.14.3 SinoCellTech Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 SinoCellTech Main Business Overview
13.14.5 SinoCellTech Latest Developments
13.15 Taibang Bio
13.15.1 Taibang Bio Company Information
13.15.2 Taibang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.15.3 Taibang Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Taibang Bio Main Business Overview
13.15.5 Taibang Bio Latest Developments
13.16 Huarun Boya
13.16.1 Huarun Boya Company Information
13.16.2 Huarun Boya Human Coagulation Factor VIII Product Portfolios and Specifications
13.16.3 Huarun Boya Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Huarun Boya Main Business Overview
13.16.5 Huarun Boya Latest Developments
13.17 Shuanglin Bio
13.17.1 Shuanglin Bio Company Information
13.17.2 Shuanglin Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.17.3 Shuanglin Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Shuanglin Bio Main Business Overview
13.17.5 Shuanglin Bio Latest Developments
13.18 Yuandashuyang
13.18.1 Yuandashuyang Company Information
13.18.2 Yuandashuyang Human Coagulation Factor VIII Product Portfolios and Specifications
13.18.3 Yuandashuyang Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Yuandashuyang Main Business Overview
13.18.5 Yuandashuyang Latest Developments
13.19 Weiguang Bio
13.19.1 Weiguang Bio Company Information
13.19.2 Weiguang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
13.19.3 Weiguang Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Weiguang Bio Main Business Overview
13.19.5 Weiguang Bio Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Coagulation Factor VIII Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Coagulation Factor VIII Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Factor VIII
Table 4. Major Players of Plasma-derived Factor VIII
Table 5. Global Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 6. Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 7. Global Human Coagulation Factor VIII Revenue by Type (2020-2025) & ($ million)
Table 8. Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2025)
Table 9. Global Human Coagulation Factor VIII Sale Price by Type (2020-2025) & (USD/Bottle)
Table 10. Global Human Coagulation Factor VIII Sale by Application (2020-2025) & (K Bottles)
Table 11. Global Human Coagulation Factor VIII Sale Market Share by Application (2020-2025)
Table 12. Global Human Coagulation Factor VIII Revenue by Application (2020-2025) & ($ million)
Table 13. Global Human Coagulation Factor VIII Revenue Market Share by Application (2020-2025)
Table 14. Global Human Coagulation Factor VIII Sale Price by Application (2020-2025) & (USD/Bottle)
Table 15. Global Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 16. Global Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 17. Global Human Coagulation Factor VIII Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 19. Global Human Coagulation Factor VIII Sale Price by Company (2020-2025) & (USD/Bottle)
Table 20. Key Manufacturers Human Coagulation Factor VIII Producing Area Distribution and Sales Area
Table 21. Players Human Coagulation Factor VIII Products Offered
Table 22. Human Coagulation Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Coagulation Factor VIII Sales by Geographic Region (2020-2025) & (K Bottles)
Table 26. Global Human Coagulation Factor VIII Sales Market Share Geographic Region (2020-2025)
Table 27. Global Human Coagulation Factor VIII Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Human Coagulation Factor VIII Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Human Coagulation Factor VIII Sales by Country/Region (2020-2025) & (K Bottles)
Table 30. Global Human Coagulation Factor VIII Sales Market Share by Country/Region (2020-2025)
Table 31. Global Human Coagulation Factor VIII Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Human Coagulation Factor VIII Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 34. Americas Human Coagulation Factor VIII Sales Market Share by Country (2020-2025)
Table 35. Americas Human Coagulation Factor VIII Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 37. Americas Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 38. APAC Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
Table 39. APAC Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
Table 40. APAC Human Coagulation Factor VIII Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 42. APAC Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 43. Europe Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 44. Europe Human Coagulation Factor VIII Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 46. Europe Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 47. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 48. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 50. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 51. Key Market Drivers & Growth Opportunities of Human Coagulation Factor VIII
Table 52. Key Market Challenges & Risks of Human Coagulation Factor VIII
Table 53. Key Industry Trends of Human Coagulation Factor VIII
Table 54. Human Coagulation Factor VIII Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Coagulation Factor VIII Distributors List
Table 57. Human Coagulation Factor VIII Customer List
Table 58. Global Human Coagulation Factor VIII Sales Forecast by Region (2026-2031) & (K Bottles)
Table 59. Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Human Coagulation Factor VIII Sales Forecast by Country (2026-2031) & (K Bottles)
Table 61. Americas Human Coagulation Factor VIII Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Human Coagulation Factor VIII Sales Forecast by Region (2026-2031) & (K Bottles)
Table 63. APAC Human Coagulation Factor VIII Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Human Coagulation Factor VIII Sales Forecast by Country (2026-2031) & (K Bottles)
Table 65. Europe Human Coagulation Factor VIII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Human Coagulation Factor VIII Sales Forecast by Country (2026-2031) & (K Bottles)
Table 67. Middle East & Africa Human Coagulation Factor VIII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Human Coagulation Factor VIII Sales Forecast by Type (2026-2031) & (K Bottles)
Table 69. Global Human Coagulation Factor VIII Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Human Coagulation Factor VIII Sales Forecast by Application (2026-2031) & (K Bottles)
Table 71. Global Human Coagulation Factor VIII Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72.Takeda Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 73.Takeda Human Coagulation Factor VIII Product Portfolios and Specifications
Table 74.Takeda Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 75.Takeda Main Business
Table 76.Takeda Latest Developments
Table 77. Bayer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Human Coagulation Factor VIII Product Portfolios and Specifications
Table 79. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. CSL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Human Coagulation Factor VIII Product Portfolios and Specifications
Table 84. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 85. CSL Main Business
Table 86. CSL Latest Developments
Table 87. Pfizer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Human Coagulation Factor VIII Product Portfolios and Specifications
Table 89. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Grifols Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 93. Grifols Human Coagulation Factor VIII Product Portfolios and Specifications
Table 94. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 95. Grifols Main Business
Table 96. Grifols Latest Developments
Table 97. Biogen Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 98. Biogen Human Coagulation Factor VIII Product Portfolios and Specifications
Table 99. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 100. Biogen Main Business
Table 101. Biogen Latest Developments
Table 102. Octapharma Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 103. Octapharma Human Coagulation Factor VIII Product Portfolios and Specifications
Table 104. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 105. Octapharma Main Business
Table 106. Octapharma Latest Developments
Table 107. NovoNordisk Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 108. NovoNordisk Human Coagulation Factor VIII Product Portfolios and Specifications
Table 109. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 110. NovoNordisk Main Business
Table 111. NovoNordisk Latest Developments
Table 112. Greencross Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 113. Greencross Human Coagulation Factor VIII Product Portfolios and Specifications
Table 114. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 115. Greencross Main Business
Table 116. Greencross Latest Developments
Table 117. Kedrion Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 118. Kedrion Human Coagulation Factor VIII Product Portfolios and Specifications
Table 119. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 120. Kedrion Main Business
Table 121. Kedrion Latest Developments
Table 122. BPL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 123. BPL Human Coagulation Factor VIII Product Portfolios and Specifications
Table 124. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 125. BPL Main Business
Table 126. BPL Latest Developments
Table 127. Hualan Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 128. Hualan Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 129. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 130. Hualan Bio Main Business
Table 131. Hualan Bio Latest Developments
Table 132. RAAS Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 133. RAAS Human Coagulation Factor VIII Product Portfolios and Specifications
Table 134. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 135. RAAS Main Business
Table 136. RAAS Latest Developments
Table 137. SinoCellTech Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 138. SinoCellTech Human Coagulation Factor VIII Product Portfolios and Specifications
Table 139. SinoCellTech Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 140. SinoCellTech Main Business
Table 141. SinoCellTech Latest Developments
Table 142.Taibang Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 143.Taibang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 144.Taibang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 145.Taibang Bio Main Business
Table 146.Taibang Bio Latest Developments
Table 147. Huarun Boya Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 148. Huarun Boya Human Coagulation Factor VIII Product Portfolios and Specifications
Table 149. Huarun Boya Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 150. Huarun Boya Main Business
Table 151. Huarun Boya Latest Developments
Table 152. Shuanglin Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 153. Shuanglin Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 154. Shuanglin Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 155. Shuanglin Bio Main Business
Table 156. Shuanglin Bio Latest Developments
Table 157. Yuandashuyang Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 158. Yuandashuyang Human Coagulation Factor VIII Product Portfolios and Specifications
Table 159. Yuandashuyang Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 160. Yuandashuyang Main Business
Table 161. Yuandashuyang Latest Developments
Table 162. Weiguang Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 163. Weiguang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 164. Weiguang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 165. Weiguang Bio Main Business
Table 166. Weiguang Bio Latest Developments
Table 1. Human Coagulation Factor VIII Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Human Coagulation Factor VIII Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Factor VIII
Table 4. Major Players of Plasma-derived Factor VIII
Table 5. Global Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 6. Global Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Table 7. Global Human Coagulation Factor VIII Revenue by Type (2020-2025) & ($ million)
Table 8. Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2025)
Table 9. Global Human Coagulation Factor VIII Sale Price by Type (2020-2025) & (USD/Bottle)
Table 10. Global Human Coagulation Factor VIII Sale by Application (2020-2025) & (K Bottles)
Table 11. Global Human Coagulation Factor VIII Sale Market Share by Application (2020-2025)
Table 12. Global Human Coagulation Factor VIII Revenue by Application (2020-2025) & ($ million)
Table 13. Global Human Coagulation Factor VIII Revenue Market Share by Application (2020-2025)
Table 14. Global Human Coagulation Factor VIII Sale Price by Application (2020-2025) & (USD/Bottle)
Table 15. Global Human Coagulation Factor VIII Sales by Company (2020-2025) & (K Bottles)
Table 16. Global Human Coagulation Factor VIII Sales Market Share by Company (2020-2025)
Table 17. Global Human Coagulation Factor VIII Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Human Coagulation Factor VIII Revenue Market Share by Company (2020-2025)
Table 19. Global Human Coagulation Factor VIII Sale Price by Company (2020-2025) & (USD/Bottle)
Table 20. Key Manufacturers Human Coagulation Factor VIII Producing Area Distribution and Sales Area
Table 21. Players Human Coagulation Factor VIII Products Offered
Table 22. Human Coagulation Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Human Coagulation Factor VIII Sales by Geographic Region (2020-2025) & (K Bottles)
Table 26. Global Human Coagulation Factor VIII Sales Market Share Geographic Region (2020-2025)
Table 27. Global Human Coagulation Factor VIII Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Human Coagulation Factor VIII Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Human Coagulation Factor VIII Sales by Country/Region (2020-2025) & (K Bottles)
Table 30. Global Human Coagulation Factor VIII Sales Market Share by Country/Region (2020-2025)
Table 31. Global Human Coagulation Factor VIII Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Human Coagulation Factor VIII Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 34. Americas Human Coagulation Factor VIII Sales Market Share by Country (2020-2025)
Table 35. Americas Human Coagulation Factor VIII Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 37. Americas Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 38. APAC Human Coagulation Factor VIII Sales by Region (2020-2025) & (K Bottles)
Table 39. APAC Human Coagulation Factor VIII Sales Market Share by Region (2020-2025)
Table 40. APAC Human Coagulation Factor VIII Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 42. APAC Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 43. Europe Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 44. Europe Human Coagulation Factor VIII Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 46. Europe Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 47. Middle East & Africa Human Coagulation Factor VIII Sales by Country (2020-2025) & (K Bottles)
Table 48. Middle East & Africa Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Human Coagulation Factor VIII Sales by Type (2020-2025) & (K Bottles)
Table 50. Middle East & Africa Human Coagulation Factor VIII Sales by Application (2020-2025) & (K Bottles)
Table 51. Key Market Drivers & Growth Opportunities of Human Coagulation Factor VIII
Table 52. Key Market Challenges & Risks of Human Coagulation Factor VIII
Table 53. Key Industry Trends of Human Coagulation Factor VIII
Table 54. Human Coagulation Factor VIII Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Human Coagulation Factor VIII Distributors List
Table 57. Human Coagulation Factor VIII Customer List
Table 58. Global Human Coagulation Factor VIII Sales Forecast by Region (2026-2031) & (K Bottles)
Table 59. Global Human Coagulation Factor VIII Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Human Coagulation Factor VIII Sales Forecast by Country (2026-2031) & (K Bottles)
Table 61. Americas Human Coagulation Factor VIII Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Human Coagulation Factor VIII Sales Forecast by Region (2026-2031) & (K Bottles)
Table 63. APAC Human Coagulation Factor VIII Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Human Coagulation Factor VIII Sales Forecast by Country (2026-2031) & (K Bottles)
Table 65. Europe Human Coagulation Factor VIII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Human Coagulation Factor VIII Sales Forecast by Country (2026-2031) & (K Bottles)
Table 67. Middle East & Africa Human Coagulation Factor VIII Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Human Coagulation Factor VIII Sales Forecast by Type (2026-2031) & (K Bottles)
Table 69. Global Human Coagulation Factor VIII Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Human Coagulation Factor VIII Sales Forecast by Application (2026-2031) & (K Bottles)
Table 71. Global Human Coagulation Factor VIII Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72.Takeda Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 73.Takeda Human Coagulation Factor VIII Product Portfolios and Specifications
Table 74.Takeda Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 75.Takeda Main Business
Table 76.Takeda Latest Developments
Table 77. Bayer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Human Coagulation Factor VIII Product Portfolios and Specifications
Table 79. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. CSL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 83. CSL Human Coagulation Factor VIII Product Portfolios and Specifications
Table 84. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 85. CSL Main Business
Table 86. CSL Latest Developments
Table 87. Pfizer Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Human Coagulation Factor VIII Product Portfolios and Specifications
Table 89. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 90. Pfizer Main Business
Table 91. Pfizer Latest Developments
Table 92. Grifols Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 93. Grifols Human Coagulation Factor VIII Product Portfolios and Specifications
Table 94. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 95. Grifols Main Business
Table 96. Grifols Latest Developments
Table 97. Biogen Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 98. Biogen Human Coagulation Factor VIII Product Portfolios and Specifications
Table 99. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 100. Biogen Main Business
Table 101. Biogen Latest Developments
Table 102. Octapharma Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 103. Octapharma Human Coagulation Factor VIII Product Portfolios and Specifications
Table 104. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 105. Octapharma Main Business
Table 106. Octapharma Latest Developments
Table 107. NovoNordisk Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 108. NovoNordisk Human Coagulation Factor VIII Product Portfolios and Specifications
Table 109. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 110. NovoNordisk Main Business
Table 111. NovoNordisk Latest Developments
Table 112. Greencross Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 113. Greencross Human Coagulation Factor VIII Product Portfolios and Specifications
Table 114. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 115. Greencross Main Business
Table 116. Greencross Latest Developments
Table 117. Kedrion Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 118. Kedrion Human Coagulation Factor VIII Product Portfolios and Specifications
Table 119. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 120. Kedrion Main Business
Table 121. Kedrion Latest Developments
Table 122. BPL Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 123. BPL Human Coagulation Factor VIII Product Portfolios and Specifications
Table 124. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 125. BPL Main Business
Table 126. BPL Latest Developments
Table 127. Hualan Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 128. Hualan Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 129. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 130. Hualan Bio Main Business
Table 131. Hualan Bio Latest Developments
Table 132. RAAS Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 133. RAAS Human Coagulation Factor VIII Product Portfolios and Specifications
Table 134. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 135. RAAS Main Business
Table 136. RAAS Latest Developments
Table 137. SinoCellTech Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 138. SinoCellTech Human Coagulation Factor VIII Product Portfolios and Specifications
Table 139. SinoCellTech Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 140. SinoCellTech Main Business
Table 141. SinoCellTech Latest Developments
Table 142.Taibang Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 143.Taibang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 144.Taibang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 145.Taibang Bio Main Business
Table 146.Taibang Bio Latest Developments
Table 147. Huarun Boya Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 148. Huarun Boya Human Coagulation Factor VIII Product Portfolios and Specifications
Table 149. Huarun Boya Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 150. Huarun Boya Main Business
Table 151. Huarun Boya Latest Developments
Table 152. Shuanglin Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 153. Shuanglin Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 154. Shuanglin Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 155. Shuanglin Bio Main Business
Table 156. Shuanglin Bio Latest Developments
Table 157. Yuandashuyang Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 158. Yuandashuyang Human Coagulation Factor VIII Product Portfolios and Specifications
Table 159. Yuandashuyang Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 160. Yuandashuyang Main Business
Table 161. Yuandashuyang Latest Developments
Table 162. Weiguang Bio Basic Information, Human Coagulation Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 163. Weiguang Bio Human Coagulation Factor VIII Product Portfolios and Specifications
Table 164. Weiguang Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue ($ Million), Price (USD/Bottle) and Gross Margin (2020-2025)
Table 165. Weiguang Bio Main Business
Table 166. Weiguang Bio Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Coagulation Factor VIII
Figure 2. Human Coagulation Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Coagulation Factor VIII Sales Growth Rate 2020-2031 (K Bottles)
Figure 7. Global Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Coagulation Factor VIII Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Coagulation Factor VIII Sales Market Share by Country/Region (2024)
Figure 10. Human Coagulation Factor VIII Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant Factor VIII
Figure 12. Product Picture of Plasma-derived Factor VIII
Figure 13. Global Human Coagulation Factor VIII Sales Market Share by Type in 2025
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2025)
Figure 15. Human Coagulation Factor VIII Consumed in Hemophilia A
Figure 16. Global Human Coagulation Factor VIII Market: Hemophilia A (2020-2025) & (K Bottles)
Figure 17. Human Coagulation Factor VIII Consumed in Spontanous / Trauma
Figure 18. Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2020-2025) & (K Bottles)
Figure 19. Human Coagulation Factor VIII Consumed in Surgical
Figure 20. Global Human Coagulation Factor VIII Market: Surgical (2020-2025) & (K Bottles)
Figure 21. Human Coagulation Factor VIII Consumed in Other
Figure 22. Global Human Coagulation Factor VIII Market: Other (2020-2025) & (K Bottles)
Figure 23. Global Human Coagulation Factor VIII Sale Market Share by Application (2024)
Figure 24. Global Human Coagulation Factor VIII Revenue Market Share by Application in 2025
Figure 25. Human Coagulation Factor VIII Sales by Company in 2025 (K Bottles)
Figure 26. Global Human Coagulation Factor VIII Sales Market Share by Company in 2025
Figure 27. Human Coagulation Factor VIII Revenue by Company in 2025 ($ millions)
Figure 28. Global Human Coagulation Factor VIII Revenue Market Share by Company in 2025
Figure 29. Global Human Coagulation Factor VIII Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Human Coagulation Factor VIII Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 32. Americas Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 33. APAC Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 34. APAC Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 35. Europe Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 36. Europe Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 38. Middle East & Africa Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 39. Americas Human Coagulation Factor VIII Sales Market Share by Country in 2025
Figure 40. Americas Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Figure 41. Americas Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 42. Americas Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 43. United States Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Human Coagulation Factor VIII Sales Market Share by Region in 2025
Figure 48. APAC Human Coagulation Factor VIII Revenue Market Share by Region (2020-2025)
Figure 49. APAC Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 50. APAC Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 51. China Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 55. India Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Human Coagulation Factor VIII Sales Market Share by Country in 2025
Figure 59. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Figure 60. Europe Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 61. Europe Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 62. Germany Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 63. France Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 70. Egypt Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII in 2025
Figure 76. Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure 77. Industry Chain Structure of Human Coagulation Factor VIII
Figure 78. Channels of Distribution
Figure 79. Global Human Coagulation Factor VIII Sales Market Forecast by Region (2026-2031)
Figure 80. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Human Coagulation Factor VIII
Figure 2. Human Coagulation Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Coagulation Factor VIII Sales Growth Rate 2020-2031 (K Bottles)
Figure 7. Global Human Coagulation Factor VIII Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Human Coagulation Factor VIII Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Human Coagulation Factor VIII Sales Market Share by Country/Region (2024)
Figure 10. Human Coagulation Factor VIII Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant Factor VIII
Figure 12. Product Picture of Plasma-derived Factor VIII
Figure 13. Global Human Coagulation Factor VIII Sales Market Share by Type in 2025
Figure 14. Global Human Coagulation Factor VIII Revenue Market Share by Type (2020-2025)
Figure 15. Human Coagulation Factor VIII Consumed in Hemophilia A
Figure 16. Global Human Coagulation Factor VIII Market: Hemophilia A (2020-2025) & (K Bottles)
Figure 17. Human Coagulation Factor VIII Consumed in Spontanous / Trauma
Figure 18. Global Human Coagulation Factor VIII Market: Spontanous / Trauma (2020-2025) & (K Bottles)
Figure 19. Human Coagulation Factor VIII Consumed in Surgical
Figure 20. Global Human Coagulation Factor VIII Market: Surgical (2020-2025) & (K Bottles)
Figure 21. Human Coagulation Factor VIII Consumed in Other
Figure 22. Global Human Coagulation Factor VIII Market: Other (2020-2025) & (K Bottles)
Figure 23. Global Human Coagulation Factor VIII Sale Market Share by Application (2024)
Figure 24. Global Human Coagulation Factor VIII Revenue Market Share by Application in 2025
Figure 25. Human Coagulation Factor VIII Sales by Company in 2025 (K Bottles)
Figure 26. Global Human Coagulation Factor VIII Sales Market Share by Company in 2025
Figure 27. Human Coagulation Factor VIII Revenue by Company in 2025 ($ millions)
Figure 28. Global Human Coagulation Factor VIII Revenue Market Share by Company in 2025
Figure 29. Global Human Coagulation Factor VIII Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Human Coagulation Factor VIII Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 32. Americas Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 33. APAC Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 34. APAC Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 35. Europe Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 36. Europe Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Human Coagulation Factor VIII Sales 2020-2025 (K Bottles)
Figure 38. Middle East & Africa Human Coagulation Factor VIII Revenue 2020-2025 ($ millions)
Figure 39. Americas Human Coagulation Factor VIII Sales Market Share by Country in 2025
Figure 40. Americas Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Figure 41. Americas Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 42. Americas Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 43. United States Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Human Coagulation Factor VIII Sales Market Share by Region in 2025
Figure 48. APAC Human Coagulation Factor VIII Revenue Market Share by Region (2020-2025)
Figure 49. APAC Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 50. APAC Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 51. China Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 55. India Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Human Coagulation Factor VIII Sales Market Share by Country in 2025
Figure 59. Europe Human Coagulation Factor VIII Revenue Market Share by Country (2020-2025)
Figure 60. Europe Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 61. Europe Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 62. Germany Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 63. France Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Human Coagulation Factor VIII Sales Market Share by Application (2020-2025)
Figure 70. Egypt Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Human Coagulation Factor VIII Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Human Coagulation Factor VIII in 2025
Figure 76. Manufacturing Process Analysis of Human Coagulation Factor VIII
Figure 77. Industry Chain Structure of Human Coagulation Factor VIII
Figure 78. Channels of Distribution
Figure 79. Global Human Coagulation Factor VIII Sales Market Forecast by Region (2026-2031)
Figure 80. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Human Coagulation Factor VIII Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Human Coagulation Factor VIII Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Human Coagulation Factor VIII Revenue Market Share Forecast by Application (2026-2031)
